Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mulberry leaf extract + black tea extract is a combination of botanical extracts commonly formulated as a dietary supplement. Mulberry leaf (Morus spp.) contains compounds that may inhibit carbohydrate absorption and lower blood sugar, while black tea (Camellia sinensis) is rich in polyphenols with antioxidant properties. The rationale for combining these extracts includes potential effects on reducing carbohydrate and fat absorption, modulating lipid profiles, and supporting metabolic health. Preclinical studies suggest the combination can increase fecal fat excretion and improve serum triglyceride/HDL cholesterol ratios but does not significantly reduce weight gain in animal models; high doses may be hepatotoxic[1][3]. This combination is primarily marketed for weight management or metabolic support but lacks robust clinical evidence for efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mulberry leaf extract + black tea extract.